TPCW
GH icon

TD Private Client Wealth’s Guardant Health GH Stock Holding History

TD Private Client Wealth’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6
Closed -$397 – 1250
2022
Q1 		$397 Buy
+6
New +$411 ﹤0.01% 1246

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

TD Private Client Wealth's GH Position: Q2 2022 in Review

TD Private Client Wealth sold out of Guardant Health (GH) in Q2 2022, closing a stake of 6 shares — an estimated $397 sold.

TD Private Client Wealth first reported a position in GH in Q1 2022 and held it in 1 quarter. The position peaked at $397 in Q1 2022. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • TD Private Client Wealth reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • TD Private Client Wealth sold 6 Guardant Health shares in Q2 2022, an estimated $397.
  • TD Private Client Wealth first reported a position in Guardant Health in Q1 2022 and held it in 1 quarter.
  • TD Private Client Wealth's Guardant Health position peaked at $397 in Q1 2022.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on TD Private Client Wealth's 13F filing for Q2 2022, filed 16 Aug 2024.